Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, a recent observational study found.
Efficacy was established based on the time to first occurrence of a primary composite endpoint event, defined as onset of persistent 50% or greater reduction in eGFR according to the Chronic Kidney ...
Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling) in the general population, which ...
Body weight cycling, also known as “yo-yo dieting,” is associated with a 25%-36% increased risk for diabetic kidney disease ...
2d
GlobalData on MSNTravere takes rare disease kidney drug to FDA despite failed trialTravere’s stock price climbed by 14% following the announcement that it will seek an FDA label expansion for Filspari.
As chronic kidney disease (CKD) management evolves, new findings from Spherix Global Insights’ annual Patient Chart Dynamix™: CKD Non-Dialysis (US) service reveal ...
Kidney health is essential for your overall health and one of the best ways to measure it is through your creatinine levels ...
Adults with type 1 diabetes who partake in weight cycling and repeatedly lose and regain body weight are more likely to develop diabetic kidney disease, researchers reported in The Journal of Clinical ...
Adults in Tanzania living with HIV and taking tenofovir have a higher rate of chronic kidney disease vs. those without the ...
Patients with CKD who use antiresorptive drugs for tumor-related disorders or oral corticosteroids may be at increased risk for osteonecrosis of the jaw.
Patients had a higher risk for eGFR decline, doubling of serum creatinine, and stage 3 chronic kidney disease over 6 years. Risk of moderate or severe albuminuria was not significant. Body-weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results